Please login to the form below

Not currently logged in
Email:
Password:

Allergan appoints financial head

Jim Hindman named chief financial officer

Allergan has appointed Jim Hindman as the company's' new chief financial officer.

Hindman replaces Jeff Edwards who steps down after nine years in the role due to family commitments.

David Pyott, Allergan's chairman and CEO paid tribute to Edwards who spent 21 years in total at the company.

"Jeff's strong work ethic and complete dedication have defined his tenure, and his many contributions across several roles have helped build Allergan into the successful company it is today.”

"Jeff's decision reflects his strong values, and we support him and are glad that we are able to make this transition in accordance with his wishes.”

Hindman is another Allergan veteran joining the company in 1984 and serving as senior VP, treasury, risk and investor relations since 2002.

Pyott said: “Jim has been an instrumental member of our organization for many years, and particularly during the past few months, has played an important leadership role.”

Hindman assumes his position at a testing time for Allergan, with the company currently fending off a hostile takeover bid from Canada's Valeant Pharmaceuticals.

Article by
Thomas Meek

21st August 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics